Baxter bone graft gets green light for spine surgery

Alan Condon -   Print  |

Orthobiologics company Baxter has received FDA clearance July 9 for its Altapore Shape Bioactive Bone Graft for spine surgery, according to Biospace.

Three things to know:

1. Altapore Shape is designed to promote bone growth and facilitate spinal fusion.

2. The product is used as a standalone bone graft substitute or as an autograft extender to fill gaps in the skeletal system, including the posterolateral spine and extremities.

3. Altapore Shape's porosity boosts cellular activity by providing more surface area for cells to travel across the bone graft.

More articles on biologics:
Setting spine practices up for success post-pandemic: 5 industry insights
UAMS begins data gathering initiative with spine patients
3 spine surgeons on the move in June

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers